A study by the Montreal Heart Institute and Innovaderm Research, Inc., has found that a treatment for psoriasis, a chronic inflammatory disease of the skin and joints, could also decrease the associated risk of vascular inflammation, a major contributor to heart disease and attacks. The study set out to see if patients with psoriasis who were treated with adalimumab to reduce skin inflammation would also demonstrate a decrease in vascular inflammation. The results show there was a...
↧
